United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	20,488	15,752	10,333	12,674	9,731	6,746
Market Cap Growth	24.18%	52.44%	-18.47%	30.24%	44.26%	74.53%
Enterprise Value	16,154	11,546	6,197	9,415	7,022	4,738
Last Close Price	475.85	352.84	219.89	278.09	216.08	151.79
PE Ratio	18.04	13.18	10.49	17.43	20.45	13.10
Forward PE	16.82	12.17	9.93	13.57	13.45	11.39
PS Ratio	6.80	5.48	4.44	6.55	5.77	4.55
PB Ratio	3.10	2.44	1.73	2.64	2.46	1.99
P/TBV Ratio	3.16	2.49	1.76	2.67	2.49	2.08
P/FCF Ratio	18.26	14.58	13.82	19.10	20.38	9.69
P/OCF Ratio	13.17	11.87	10.57	15.79	16.27	8.93
PEG Ratio	3.14	1.02	13.47	1.03	0.72	1.27
EV/Sales Ratio	5.16	4.01	2.66	4.86	4.17	3.19
EV/EBITDA Ratio	10.07	7.60	5.00	9.05	9.53	7.33
EV/EBIT Ratio	10.62	7.98	5.23	9.52	10.22	7.94
EV/FCF Ratio	14.40	10.69	8.29	14.19	14.71	6.80
Debt / Equity Ratio	-	0.05	0.12	0.17	0.20	0.24
Debt / EBITDA Ratio	-	0.22	0.56	0.77	1.09	1.24
Debt / FCF Ratio	-	0.31	0.94	1.21	1.68	1.15
Net Debt / Equity Ratio	-0.66	-0.68	-0.70	-0.70	-0.70	-0.64
Net Debt / EBITDA Ratio	-2.70	-2.90	-3.39	-3.22	-3.77	-3.38
Net Debt / FCF Ratio	-3.86	-4.07	-5.62	-5.05	-5.82	-3.14
Asset Turnover	0.43	0.40	0.35	0.35	0.35	0.35
Inventory Turnover	2.21	2.30	2.41	1.55	1.36	1.20
Quick Ratio	5.61	4.81	4.10	9.12	6.97	6.16
Current Ratio	6.40	5.25	4.41	9.85	7.61	6.70
Return on Equity (ROE)	20.04%	19.23%	18.27%	16.61%	12.94%	16.67%
Return on Assets (ROA)	13.14%	12.44%	11.22%	11.03%	8.78%	8.74%
Return on Invested Capital (ROIC)	29.22%	31.17%	28.43%	27.09%	21.21%	21.34%
Return on Capital Employed (ROCE)	22.40%	21.80%	18.60%	17.30%	14.10%	13.90%
Earnings Yield	6.21%	7.59%	9.53%	5.74%	4.89%	7.63%
FCF Yield	5.48%	6.86%	7.23%	5.24%	4.91%	10.32%
Buyback Yield / Dilution	1.38%	2.41%	-2.47%	-2.54%	-6.05%	-1.83%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q